BDBM463309 (+-)-2-Methyl-3-(benzimidazol- 4-ylmethylamino)-N-(9- chloro-3,4-dihydro-2H-1,5- benzodioxepin-7-ylmethyl)-N- isobutylpropanamide::US10780095, Structure TABLE 1.7

SMILES CC(C)CN(Cc1cc(Cl)c2OCCCOc2c1)C(=O)C(C)CNCc1cccc2nc[nH]c12

InChI Key InChIKey=AJYKZRXAHQYRHZ-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 463309   

TargetProkineticin receptor 2(Human)
University of California

US Patent
LigandPNGBDBM463309((+-)-2-Methyl-3-(benzimidazol- 4-ylmethylamino)-N-...)
Affinity DataKi:  2.10nMAssay Description:An aequorin-based luminescent assay for calcium mobilization was used to measure mobilization of intracellular Ca2+ (Bullock et al., Mol Pharmacol 65...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2021
Entry Details
Go to US Patent

TargetProkineticin receptor 1(Human)
University of California

US Patent
LigandPNGBDBM463309((+-)-2-Methyl-3-(benzimidazol- 4-ylmethylamino)-N-...)
Affinity DataKi:  5.60nMAssay Description:An aequorin-based luminescent assay for calcium mobilization was used to measure mobilization of intracellular Ca2+ (Bullock et al., Mol Pharmacol 65...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2021
Entry Details
Go to US Patent